Working for increased Alzheimer’s disease research funding

Opinion section
Valley News - Opinion

Congressman Ken Calvert, U.S. House of Representatives

I appreciate Aaron Manley writing in [Increase funding for Alzheimer’s disease research, May 21, 2020] to advocate for Alzheimer’s disease and dementia research funding. The heartbreaking loss he suffered with the loss of his mother to Alzheimer’s disease is something far too many families have had to endure.

I completely agree with Manley that funding is essential to finding cures and treatment. That’s why I am a member of the Congressional Task Force on Alzheimer’s disease. Thanks to the powerful advocacy of individuals like Manley and the leadership of the task force, Congress approved a $350 million increase – $2.8 billion in total funding – for Alzheimer’s disease and dementia research funding at the National Institutes of Health in December.

I am also a co-sponsor of the Younger Onset Alzheimer’s Act, H.R. 1903, which would allow individuals under 60 years of age diagnosed with Younger-Onset Alzheimer’s disease to be eligible to access programs in the Older Americans Act, including nutritional and other programs providing temporary relief to caregivers.

I will continue to be a champion for Alzheimer’s disease and dementia research and stand side-by-side with people, like Manley, who are fighting for cures, treatments and hope for those afflicted with this terrible disease.